The 110-acre site had been used for pharmaceutical manufacturing operations since the early 1970s, as well as research and development and corporate offices. ESI performed a PA/SI of the entire site, reviewed historical environmental remediation reports, and identified over sixteen potential AOCs.
ESI conducted soil investigations at some of the AOCs and removed a former heating oil UST that was discovered in the process. ESI re-evaluated an active groundwater contamination case on the property and implemented a more effective remedial approach, significantly decreasing the groundwater contaminant plume.
The LSRP has issued Response Action Outcomes (RAOs) for all the AOCs associated with the ISRA case with the exception of groundwater. Once the groundwater treatment is completed, a site-wide RAO will be issued for ISRA case closure. The property was subsequently sold and being redeveloped for a mixed residential/commercial use.
